EI
SZYM

EAM Investors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

EAM Investors’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-99,606
Closed -$1.17M – 407
2013
Q2 		$1.17M Buy
+99,606
New +$995K 0.25% 155

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EAM Investors's SZYM Position: Q3 2013 in Review

EAM Investors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q3 2013, closing a stake of 99,606 shares — an estimated $1.17M sold.

EAM Investors first reported a position in SZYM in Q2 2013 and held it in 1 quarter. The position peaked at $1.17M in Q2 2013. 108 funds tracked by Wall St. Rank hold SZYM as of Q3 2013.

  • EAM Investors reported no remaining SOLAZYME INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • EAM Investors sold 99,606 SOLAZYME INC COM STK (DE) shares in Q3 2013, an estimated $1.17M.
  • EAM Investors first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • EAM Investors's SOLAZYME INC COM STK (DE) position peaked at $1.17M in Q2 2013.
  • 108 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q3 2013.

Based on EAM Investors's 13F filing for Q3 2013, filed 13 Nov 2013.